This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1993:33:281-307.

doi: 10.1146/annurev.pa.33.040193.001433.

Molecular diversity of the dopamine receptors

O Civelli¹, J R Bunzow, D K Grandy

Affiliations

PMID: 8494342
DOI: 10.1146/annurev.pa.33.040193.001433

Review

Molecular diversity of the dopamine receptors

O Civelli et al. Annu Rev Pharmacol Toxicol. 1993.

. 1993:33:281-307.

doi: 10.1146/annurev.pa.33.040193.001433.

Authors

O Civelli¹, J R Bunzow, D K Grandy

Affiliation

¹ Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.

PMID: 8494342
DOI: 10.1146/annurev.pa.33.040193.001433

No abstract available

PubMed Disclaimer

Similar articles

Dopamine receptor diversity: molecular and pharmacological perspectives.
Hartman DS, Civelli O. Hartman DS, et al. Prog Drug Res. 1997;48:173-94. doi: 10.1007/978-3-0348-8861-5_7. Prog Drug Res. 1997. PMID: 9204687 Review. No abstract available.
Current concepts in the molecular diversity and pharmacology of dopamine receptors.
Kulkarni SK, Ninan I. Kulkarni SK, et al. Methods Find Exp Clin Pharmacol. 1996 Nov;18(9):599-613. Methods Find Exp Clin Pharmacol. 1996. PMID: 9010835 Review. No abstract available.
Role of the fourth intracellular loop of D1-like dopaminergic receptors in conferring subtype-specific signaling properties.
Tumova K, Zhang D, Tiberi M. Tumova K, et al. FEBS Lett. 2004 Oct 22;576(3):461-7. doi: 10.1016/j.febslet.2004.09.059. FEBS Lett. 2004. PMID: 15498581
Molecular biology of dopamine receptors.
Sibley DR, Monsma FJ Jr. Sibley DR, et al. Trends Pharmacol Sci. 1992 Feb;13(2):61-9. doi: 10.1016/0165-6147(92)90025-2. Trends Pharmacol Sci. 1992. PMID: 1561715 Review.
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Sokoloff P, et al. Nature. 1990 Sep 13;347(6289):146-51. doi: 10.1038/347146a0. Nature. 1990. PMID: 1975644

See all similar articles

Cited by

Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor.
Bhagwanth S, Mishra RK, Johnson RL. Bhagwanth S, et al. Beilstein J Org Chem. 2013;9:204-14. doi: 10.3762/bjoc.9.24. Epub 2013 Jan 30. Beilstein J Org Chem. 2013. PMID: 23400263 Free PMC article.
Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors.
Nir I, Harrison JM, Haque R, Low MJ, Grandy DK, Rubinstein M, Iuvone PM. Nir I, et al. J Neurosci. 2002 Mar 15;22(6):2063-73. doi: 10.1523/JNEUROSCI.22-06-02063.2002. J Neurosci. 2002. PMID: 11896146 Free PMC article.
Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro.
Lavin A, Grace AA. Lavin A, et al. J Neurosci. 1998 Dec 15;18(24):10566-78. doi: 10.1523/JNEUROSCI.18-24-10566.1998. J Neurosci. 1998. PMID: 9852593 Free PMC article.
Six-Month Synbio^® Administration Affects Nutritional and Inflammatory Parameters of Older Adults Included in the PROBIOSENIOR Project.
Salvesi C, Silvi S, Fiorini D, Alessandroni L, Sagratini G, Palermo FA, De Leone R, Egidi N, Cifani C, Micioni Di Bonaventura MV, Amedei A, Niccolai E, Scocchera F, Mannucci F, Valeriani V, Malavasi M, Servili S, Casula A, Cresci A, Corradetti I, Coman MM, Verdenelli MC. Salvesi C, et al. Microorganisms. 2023 Mar 21;11(3):801. doi: 10.3390/microorganisms11030801. Microorganisms. 2023. PMID: 36985374 Free PMC article.
Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration.
Cadet JL, Jayanthi S, McCoy MT, Beauvais G, Cai NS. Cadet JL, et al. CNS Neurol Disord Drug Targets. 2010 Nov;9(5):526-38. doi: 10.2174/187152710793361496. CNS Neurol Disord Drug Targets. 2010. PMID: 20632973 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ingenta plc
Other Literature Sources
- The Lens - Patent Citations Database
Molecular Biology Databases
- Guide to Pharmacology